What is Gilead Sciences's U.S. — total revenues?

Gilead Sciences (GILD) reported U.S. — total revenues of $4.93B in Q1 2026.

How has Gilead Sciences's U.S. — total revenues changed year-over-year?

Gilead Sciences's U.S. — total revenues increased by 5.5% year-over-year, from $4.67B to $4.93B.

What is the long-term trend for Gilead Sciences's U.S. — total revenues?

Over 4 years (2021 to 2025), Gilead Sciences's U.S. — total revenues has grown at a 2.0% compound annual growth rate (CAGR), from $19.27B to $20.88B.

Gilead Sciences GILD U.S. — Total revenues

Other financials

Income statement

See full

Revenue$7.0B+4.4%

Gross profit$5.5B+7.6%

Operating income$2.6B+15.6%

Net income$2.0B+53.7%

EPS (diluted)$1.61+54.8%

Balance sheet

See full

Cash & equivalents$7.6B-3.8%

Total debt$22.2B-11.1%

Total equity$23.5B+22.7%

Total assets$56.3B-0.3%

Cash flow

See full

Operating cash flow$2.5B+44.8%

CapEx$117.0M+12.5%

Free cash flow$2.4B+46.8%

Valuation

See full

Market cap$167.41B+20.4%

Enterprise value$181.96B+14.5%

P/E18.2×-3.9×

P/S5.6×+0.8×

Profitability

See full

Gross margin79.4%+1.1pp

Operating margin34.9%+6.3pp

Net margin31%+10.2pp

FCF margin34.4%+0.1pp

Returns & leverage

See full

Return on equity43.2%+10.7pp

Debt / equity0.9×-0.4×

Current ratio2×+0.6×

Where this comes from

Reported directly by Gilead Sciences in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The official record: Gilead Sciences’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Gilead Sciences's u.s. — total revenues.

Connect your AI assistant and see it in context, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Gilead Sciences's U.S. — total revenues?: Gilead Sciences (GILD) reported U.S. — total revenues of $4.93B in Q1 2026.
How has Gilead Sciences's U.S. — total revenues changed year-over-year?: Gilead Sciences's U.S. — total revenues increased by 5.5% year-over-year, from $4.67B to $4.93B.
What is the long-term trend for Gilead Sciences's U.S. — total revenues?: Over 4 years (2021 to 2025), Gilead Sciences's U.S. — total revenues has grown at a 2.0% compound annual growth rate (CAGR), from $19.27B to $20.88B.